Mylan NV
www.mylan.com
Latest From Mylan NV
Can Dr Reddy’s Carve Into Crowded Indian Avastin Biosimilar Market?
Dr Reddy’s debuts biosimilar bevacizumab in India but can the significant price differential for one strength of the product help it gnaw into a competitive market?
Can Dr Reddy’s Carve Into Crowded Indian Avastin Biosimilar Market?
Dr Reddy’s debuts biosimilar bevacizumab in India but can the significant price differential for one strength of the product help it gnaw into a competitive market?
US Insurer United Rewards Amgen’s Early Entry With Bevacizumab And Trastuzumab
Amgen’s Mvasi and Kanjinti alternatives to Roche’s Avastin bevacizumab and Herceptin trastuzumab brands will from 1 October be preferred by plans administered by the largest US health insurer, UnitedHealthcare.
Amgen's US Biosimilar Launches Are Off To A Steady Start, With A Big Coverage Decision
United HealthCare agreed to cover Mvasi and Kanjinti in a preferred position. Amgen VP-oncology sales & marketing Susan Logan talked to Scrip about the company's first US biosimilar launches.
Company Information
- Industry
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
- Generic Drugs
-
Drug Delivery
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Mylan Laboratories Inc.
- Mylan Inc.
- Ownership
- Public
- Headquarters
-
Worldwide
-
Europe
-
Western Europe
-
UK
-
UK
-
Western Europe
-
Europe
- Parent & Subsidiaries
-
Mylan NV
- Agila Specialties Pvt. Ltd.
- Alphapharm Pty. Ltd.
- Dow Hickam Pharmaceuticals
- Meda AB
- Merck Generics Group
- Mylan Bertek Pharmaceuticals Inc.
- Mylan Institutional
- Mylan Laboratories Ltd.
- Mylan Pharmaceuticals Inc.
- Mylan Pharmaceuticals Pvt. Ltd.
- Mylan Specialty LP
- Mylan Technologies Inc.
- Penederm Inc.
- Somerset Pharmaceuticals Inc.
- Senior Management
-
Heather Bresch, CEO
Ken D Parks, CFO
Anthony Mauro, Chief Commercial Officer - Contact Info
-
Mylan NV
Phone: 1707 853000
Bldg. 4, Trident Pl.
Mosquito Way
Hatfield, PA AL10 9UL
UK
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice